LA
WVE icon

Lee Ainslie’s Wave Life Sciences WVE Stock Holding History

Lee Ainslie’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$59.7M Buy
10,278,115
+116,716
+1% +$774K 0.53% 44
2026
Q1 		$73.7M Buy
10,161,399
+881,162
+9% +$11.5M 0.85% 37
2025
Q4 		$158M Buy
9,280,237
+888,381
+11% +$9.03M 1.69% 24
2025
Q3 		$61.4M Buy
8,391,856
+130,173
+2% +$1.05M 0.82% 36
2025
Q2 		$53.7M Hold
8,261,683
– – 0.81% 37
2025
Q1 		$66.8M Buy
8,261,683
+441
+0% +$4.82K 1.18% 31
2024
Q4 		$102M Sell
8,261,242
-1,786,278
-18% -$23.8M 1.84% 22
2024
Q3 		$82.4M Buy
10,047,520
+2,378,159
+31% +$14.2M 1.61% 22
2024
Q2 		$38.3M Sell
7,669,361
-18,718
-0.2% -$107K 0.73% 41
2024
Q1 		$47.4M Sell
7,688,079
-759,725
-9% -$3.8M 0.89% 36
2023
Q4 		$42.7M Buy
8,447,804
+1,853,485
+28% +$9.91M 0.86% 36
2023
Q3 		$37.9M Sell
6,594,319
-2,459
-0% -$11.2K 0.86% 30
2023
Q2 		$24M Hold
6,596,778
– – 0.51% 38
2023
Q1 		$28.6M Sell
6,596,778
-500,886
-7% -$2.3M 0.72% 31
2022
Q4 		$49.7M Sell
7,097,664
-707,555
-9% -$3.26M 1.18% 25
2022
Q3 		$28.2M Hold
7,805,219
– – 0.63% 33
2022
Q2 		$25.4M Buy
7,805,219
+2,211,830
+40% +$4.25M 0.63% 34
2022
Q1 		$11.2M Hold
5,593,389
– – 0.2% 64
2021
Q4 		$17.6M Buy
5,593,389
+2,400,000
+75% +$9.97M 0.2% 65
2021
Q3 		$15.6M Buy
3,193,389
+105,258
+3% +$638K 0.16% 67
2021
Q2 		$20.6M Buy
3,088,131
+4,930
+0.2% +$32.2K 0.19% 63
2021
Q1 		$17.3M Buy
+3,083,201
New +$29.6M 0.16% 60

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GP
GSK plc London $602M AUM
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RAM
Readystate Asset Management Chicago, Illinois $2.93B AUM 18.57% 1-Year Est. Return
MCM
M28 Capital Management Stamford, Connecticut $47.2M AUM 32.31% 1-Year Est. Return

Lee Ainslie's WVE Position: Q2 2026 in Review

Lee Ainslie increased its Wave Life Sciences (WVE) stake by 1.1% in Q2 2026, buying an estimated $774K and bringing the position to 10,278,115 shares worth $59.7M. The position accounts for 0.53% of the portfolio, ranked #44.

Lee Ainslie first reported a position in WVE in Q1 2021 and has held it in 22 quarters since. The position peaked at $158M in Q4 2025. 238 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

  • Lee Ainslie held 10,278,115 shares of Wave Life Sciences worth $59.7M as of Q2 2026.
  • Lee Ainslie bought 116,716 Wave Life Sciences shares in Q2 2026, an estimated $774K.
  • Wave Life Sciences made up 0.53% of Lee Ainslie's portfolio in Q2 2026, its #44 holding.
  • Lee Ainslie first reported a position in Wave Life Sciences in Q1 2021 and has held it in 22 quarters since.
  • Lee Ainslie's Wave Life Sciences position peaked at $158M in Q4 2025.
  • 238 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on Maverick Capital's 13F filing for Q2 2026, filed 14 Aug 2026.